Cargando...

Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials

Triple-negative breast cancer (TNBC) is an aggressive malignancy with a poor prognosis despite the high rates of response to chemotherapy. This scenario highlights the need to develop novel therapies and/or treatment strategies to reduce the mortality associated with TNBC. The neoadjuvant setting pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amos, Keith D., Adamo, Barbara, Anders, Carey K.
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3270519/
https://ncbi.nlm.nih.gov/pubmed/22461984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/385978
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!